FN Archimer Export Format PT J TI Anti-Biofilm Effect of Biodegradable Coatings Based on Hemibastadin Derivative in Marine Environment BT AF LE NORCY, Tiffany NIEMANN, Hendrik PROKSCH, Peter LINOSSIER, Isabelle VALLEE-REHEL, Karine HELLIO, Claire FAY, Fabienne AS 1:1;2:2;3:2;4:1;5:1;6:3;7:1; FF 1:;2:;3:;4:;5:;6:;7:; C1 Univ Bretagne Sud, Inst Univ Europeen Mer, Lab Biotechnol & Chim Marines, F-56100 Lorient, France. Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, D-40225 Dusseldorf, Germany. Univ Bretagne Occidentale, Inst Europeen Mer, LEMAR UMR 6539, Biodimar, F-29200 Brest, France. C2 UBS, FRANCE UNIV DUSSELDORF, GERMANY UBO, FRANCE UM LEMAR IN DOAJ IF 3.687 TC 11 UR https://archimer.ifremer.fr/doc/00616/72812/72626.pdf LA English DT Article DE ;antifouling;biodegradable coating;hemibastadin;sponges;marine bacteria;microalgae AB Dibromohemibastadin-1 (DBHB) is an already known potent inhibitor of blue mussel phenoloxidase (which is a key enzyme involved in bioadhesion). Within this study, the potentiality of DBHB against microfouling has been investigated. The activity of DBHB was evaluated on key strains of bacteria and microalgae involved in marine biofilm formation and bioassays assessing impact on growth, adhesion and biofilm formation were used. To assess the efficiency of DBHB when included in a matrix, DBHB varnish was prepared and the anti-microfouling activity of coatings was assessed. Both in vitro and in situ immersions were carried out. Confocal Laser Scanning Microscopy (CLSM) was principally used to determine the biovolume and average thickness of biofilms developed on the coatings. Results showed an evident efficiency of DBHB as compound and varnish to reduce the biofilm development. The mode of action seems to be based principally on a perturbation of biofilm formation rather than on a biocidal activity in the tested conditions. PY 2017 PD JUN SO International Journal Of Molecular Sciences SN 1422-0067 PU Mdpi Ag VL 18 IS 7 UT 000408746800189 DI 10.3390/ijms18071520 ID 72812 ER EF